EK
Insider
Edward M. MD Kaye
DirectorEdward M. MD Kaye (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $1.9M of CYTK (28,064 sh × $66.72, as filed), executed Dec 1 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.8M
shares × price, as filed
Last traded
Aug 18
Filed Aug 18
Median ADV $25.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
STOKSALE
Stoke Therapeutics, Inc.
View filing →
$382K11,930 sh × $32.01
Exec Aug 18
Filed Aug 18 · 8:28 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $223K
2,933 sh × $76.09
Exec Jun 1
Filed Jun 1 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $389K
12,099 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $360K
11,589 sh across 2 lots
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $1.9M
28,064 sh × $66.72
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $337K
5,175 sh × $65.08
Exec Nov 11 2025
Filed Nov 12 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. View filing → $750K
25,000 sh × $30.00
Exec Oct 8 2025
Filed Oct 10 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $405K
6,757 sh × $60.00
Exec Oct 6 2025
Filed Oct 6 2025 · 5:30 PM ET More filings →